世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030オリゴヌクレオチド療法の世界市場レポート2021年版：COVID 19の成長と2030年までの変化 概要 オリゴヌクレオチド療法の最大かつ最速で成長している市場はどこか？この市場は、経済全体や人口動態、他の類似市場とどのように関連しているのか？どのような力が今後の市場を形成するのか？The B... もっと見る
Summary
概要
オリゴヌクレオチド療法の最大かつ最速で成長している市場はどこか？この市場は、経済全体や人口動態、他の類似市場とどのように関連しているのか？どのような力が今後の市場を形成するのか？The Business Research Companyのオリゴヌクレオチド療法市場のグローバルレポートは、これらすべての疑問やその他多くの疑問に答えています。
本レポートでは、この市場の特徴、規模と成長、セグメンテーション、地域・国別の内訳、競合状況、市場シェア、動向、戦略などを網羅しています。地域別に市場の歴史的成長と予測を追跡しています。この市場をより広いオリゴヌクレオチド治療市場の中で位置づけ、他の市場と比較しています。
- 市場の特徴」では、市場の定義と説明をしています。
- 市場規模のセクションでは、市場の歴史的成長、Covid 19ウイルスの影響、成長予測の両方を網羅した市場規模（bドル）を示しています。
- 市場区分では、市場をサブマーケットに分類しています。
- 地域別・国別では、各地域の市場分析、地域別の市場規模、歴史的成長率と予測成長率を比較しています。全地域、主要先進国、主要新興国のCovid19の成長軌道を網羅しています。
- 競合状況では、市場の競合性、市場シェア、主要企業の説明をしています。近年の市場を形成した主要な金融取引を特定しています。
- トレンドと戦略」では、危機から脱却した市場の姿を分析し、市場の回復に合わせて企業が成長する方法を提案しています。
- レポートの「オリゴヌクレオチド療法市場」のセクションでは、背景を説明しています。オリゴヌクレオチド療法市場と他のセグメントとの比較を、規模と成長、過去と予測で行っています。GDP比率、一人当たりの支出、オリゴヌクレオチド治療指標の比較を分析しています。
調査対象範囲
対象市場:
1) タイプ別 アンチセンス・オリゴヌクレオチド、アプタマー、その他
2) アプリケーション別 2) 用途別：感染症、腫瘍、神経変性疾患、心血管疾患、腎臓疾患、その他
3) エンドユーザー別：病院、研究機関
記載されている会社 Alnylam Pharmaceuticals Inc.、Biogen Inc.、Dynavax Technologies Corp.、Ionis Pharmaceuticals Inc.、Merck & Co. Inc.などがあります。
対象国：オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国
対象地域： アジア太平洋、西欧、東欧、北米、南米、中東、アフリカ
時系列：過去5年間と10年間の予測
データ データ：市場規模と成長率の関連市場に対する比率、GDP比率、一人当たりの支出。
データ区分：国・地域別の歴史的・予測的データ、競合他社の市場シェア、市場区分
Table of Contents
Table of Contents
1. Executive Summary
2. Oligonucleotide Therapy Market Characteristics
3. Oligonucleotide Therapy Market Trends And Strategies
4. Impact Of COVID-19 On Oligonucleotide Therapy
5. Oligonucleotide Therapy Market Size And Growth
5.1. Global Oligonucleotide Therapy Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Oligonucleotide Therapy Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Oligonucleotide Therapy Market Segmentation
6.1. Global Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Antisense Oligonucleotide
Aptamer
Other
6.2. Global Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Infectious Diseases
Oncology
Neurodegenerative Disorders
Cardiovascular Diseases
Kidney Diseases
Others
6.3. Global Oligonucleotide Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Hospitals
Research Institutes
7. Oligonucleotide Therapy Market Regional And Country Analysis
7.1. Global Oligonucleotide Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Oligonucleotide Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Oligonucleotide Therapy Market
8.1. Asia-Pacific Oligonucleotide Therapy Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Oligonucleotide Therapy Market
9.1. China Oligonucleotide Therapy Market Overview
9.2. China Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Oligonucleotide Therapy Market
10.1. India Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Oligonucleotide Therapy Market
11.1. Japan Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Oligonucleotide Therapy Market
12.1. Australia Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Oligonucleotide Therapy Market
13.1. Indonesia Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Oligonucleotide Therapy Market
14.1. South Korea Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Oligonucleotide Therapy Market
15.1. Western Europe Oligonucleotide Therapy Market Overview
15.2. Western Europe Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Oligonucleotide Therapy Market
16.1. UK Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Oligonucleotide Therapy Market
17.1. Germany Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Oligonucleotide Therapy Market
18.4. France Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Oligonucleotide Therapy Market
19.1. Eastern Europe Oligonucleotide Therapy Market Overview
19.2. Eastern Europe Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Oligonucleotide Therapy Market
20.1. Russia Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Oligonucleotide Therapy Market
21.1. North America Oligonucleotide Therapy Market Overview
21.2. North America Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Oligonucleotide Therapy Market
22.1. USA Oligonucleotide Therapy Market Overview
22.2. USA Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Oligonucleotide Therapy Market
23.1. South America Oligonucleotide Therapy Market Overview
23.2. South America Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Oligonucleotide Therapy Market
24.1. Brazil Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Oligonucleotide Therapy Market
25.1. Middle East Oligonucleotide Therapy Market Overview
25.2. Middle East Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Oligonucleotide Therapy Market
26.1. Africa Oligonucleotide Therapy Market Overview
26.2. Africa Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Oligonucleotide Therapy Market Competitive Landscape And Company Profiles
27.1. Oligonucleotide Therapy Market Competitive Landscape
27.2. Oligonucleotide Therapy Market Company Profiles
27.2.1. Alnylam Pharmaceuticals Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Biogen Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Dynavax Technologies Corp.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Ionis Pharmaceuticals Inc.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Merck & Co. Inc.
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Oligonucleotide Therapy Pipeline Analysis
29. Key Mergers And Acquisitions In The Oligonucleotide Therapy Market
30. Oligonucleotide Therapy Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（バイオ薬物）の最新刊レポート
The Business Research Company (TBRC)社のバイオ薬物分野での最新刊レポート
本レポートと同じKEY WORD（oligonucleotide）の最新刊レポートよくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
